[Preparation and properties of a new artificial bone composite material].

Artificial bone composite material hyaluronic acid α-calcium sulfate hemihydrate β-tricalcium phosphate

Journal

Zhongguo xiu fu chong jian wai ke za zhi = Zhongguo xiufu chongjian waike zazhi = Chinese journal of reparative and reconstructive surgery
ISSN: 1002-1892
Titre abrégé: Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi
Pays: China
ID NLM: 9425194

Informations de publication

Date de publication:
15 Apr 2023
Historique:
medline: 19 4 2023
entrez: 18 4 2023
pubmed: 19 4 2023
Statut: ppublish

Résumé

To study the preparation and properties of the hyaluronic acid (HA)/α-calcium sulfate hemihydrate (α-CSH)/β-tricalcium phosphate (β-TCP) material (hereinafter referred to as composite material). Firstly, the α-CSH was prepared from calcium sulfate dihydrate by hydrothermal method, and the β-TCP was prepared by wet reaction of soluble calcium salt and phosphate. Secondly, the α-CSH and β-TCP were mixed in different proportions (10∶0, 9∶1, 8∶2, 7∶3, 5∶5, and 3∶7), and then mixed with HA solutions with concentrations of 0.1%, 0.25%, 0.5%, 1.0%, and 2.0%, respectively, at a liquid-solid ratio of 0.30 and 0.35 respectively to prepare HA/α-CSH/ β-TCP composite material. The α-CSH/β-TCP composite material prepared with α-CSH, β-TCP, and deionized water was used as the control. The composite material was analyzed by scanning electron microscope, X-ray diffraction analysis, initial/final setting time, degradation, compressive strength, dispersion, injectability, and cytotoxicity. The HA/α-CSH/β-TCP composite material was prepared successfully. The composite material has rough surface, densely packed irregular block particles and strip particles, and microporous structures, with the pore size mainly between 5 and 15 μm. When the content of β-TCP increased, the initial/final setting time of composite material increased, the degradation rate decreased, and the compressive strength showed a trend of first increasing and then weakening; there were significant differences between the composite materials with different α-CSH/β-TCP proportion ( The HA/α-CSH/β-TCP composite materials have good biocompatibility. Theoretically, it can meet the clinical needs of bone defect repairing, and may be a new artificial bone material with potential clinical application prospect. 探讨透明质酸(hyaluronic acid,HA)/α-半水硫酸钙(α-calcium sulfate hemihydrate,α-CSH)/β-磷酸三钙(β-tricalcium phosphate,β-TCP)复合人工骨材料(以下简称复合材料)的制备及其性能。. 采用水热法将二水硫酸钙脱水制备α-CSH,可溶性钙盐和磷酸盐反应法制备β-TCP。将α-CSH、β-TCP粉末按照不同比例(10∶0、9∶1、8∶2、7∶3、5∶5、3∶7)混合,分别与浓度为0.1%、0.25%、0.5%、1.0%、2.0%的HA溶液以及去离子水,以液固比0.30、0.35混合,制备HA/α-CSH/β-TCP、α-CSH/β-TCP复合材料。将制备样品进行扫描电镜观察、X射线衍射分析、初凝/终凝时间测定、降解测定、抗压强度测定、溃散情况观察、可注射性实验以及细胞毒性实验。. 成功制备HA/α-CSH/β-TCP复合材料。该复合材料表面粗糙,不规则片块状颗粒、条状颗粒密集堆积,表面呈微孔结构,孔径主要在5~15 μm之间。随β-TCP含量增加,复合材料初凝、终凝时间均增加,降解率降低,抗压强度呈先增加再减弱变化趋势,不同α-CSH/β-TCP比例制备材料间差异均有统计学意义( HA/α-CSH/β-TCP复合材料具有良好生物相容性,理论上可满足临床骨缺损修复需求,是一种具有潜在临床应用前景的新型人工骨材料。.

Autres résumés

Type: Publisher (chi)
探讨透明质酸(hyaluronic acid,HA)/α-半水硫酸钙(α-calcium sulfate hemihydrate,α-CSH)/β-磷酸三钙(β-tricalcium phosphate,β-TCP)复合人工骨材料(以下简称复合材料)的制备及其性能。.

Identifiants

pubmed: 37070320
doi: 10.7507/1002-1892.202211097
pmc: PMC10110745
doi:

Substances chimiques

beta-tricalcium phosphate 0
Calcium Phosphates 0
alpha-tricalcium phosphate 0
Phosphates 0

Types de publication

English Abstract Journal Article

Langues

chi

Sous-ensembles de citation

IM

Pagination

488-494

Références

Biomaterials. 1999 Feb;20(4):393-8
pubmed: 10048413
Materials (Basel). 2010 Jul 06;3(7):3867-3910
pubmed: 28883315
Adv Exp Med Biol. 2018;1059:137-153
pubmed: 29736572
Acta Biomater. 2020 Sep 1;113:23-41
pubmed: 32565369
J Biomater Appl. 2012 Jul;27(1):37-45
pubmed: 21343212
J Orthop Translat. 2015 Dec 31;5:57-68
pubmed: 30035075
Morphologie. 2017 Sep;101(334):111-112
pubmed: 28992852

Auteurs

Jianhua Ge (J)

Department of Bone and Joint Surgery, Affiliated Hospital of Southwest Medical University, Sichuan Provincial Laboratory of Orthopedic Implant Device R&D and Application Technology Engineering, Luzhou Sichuan, 646000, P. R. China.

Le Jia (L)

Department of Bone and Joint Surgery, Affiliated Hospital of Southwest Medical University, Sichuan Provincial Laboratory of Orthopedic Implant Device R&D and Application Technology Engineering, Luzhou Sichuan, 646000, P. R. China.

Ke Duan (K)

Department of Bone and Joint Surgery, Affiliated Hospital of Southwest Medical University, Sichuan Provincial Laboratory of Orthopedic Implant Device R&D and Application Technology Engineering, Luzhou Sichuan, 646000, P. R. China.

Yang Li (Y)

Department of Bone and Joint Surgery, Affiliated Hospital of Southwest Medical University, Sichuan Provincial Laboratory of Orthopedic Implant Device R&D and Application Technology Engineering, Luzhou Sichuan, 646000, P. R. China.

Yue Ma (Y)

Department of Bone and Joint Surgery, Affiliated Hospital of Southwest Medical University, Sichuan Provincial Laboratory of Orthopedic Implant Device R&D and Application Technology Engineering, Luzhou Sichuan, 646000, P. R. China.

Jiyuan Yan (J)

Department of Bone and Joint Surgery, Affiliated Hospital of Southwest Medical University, Sichuan Provincial Laboratory of Orthopedic Implant Device R&D and Application Technology Engineering, Luzhou Sichuan, 646000, P. R. China.

Xin Duan (X)

Department of Orthopedics, West China Hospital of Sichuan University, Chengdu Sichuan, 610041, P. R. China.

Guibing Wu (G)

Department of Orthopedics, Hejiang People's Hospital, Hejiang Sichuan, 646200, P. R. China.

Articles similaires

Animals Bone Morphogenetic Protein 2 Calcium Phosphates Rats Retrospective Studies
Biofilms Gene Expression Regulation, Bacterial Bacillus Phosphates Bacterial Proteins
Humans Sedentary Behavior Adolescent Bone Density Child
Horses Animals Collagen Bone and Bones Peptides

Classifications MeSH